Failure Rate of Infra-Zygomatic Orthodontic Mini-Screws
Factors Associated With the Failure Rate of Infra-Zygomatic Orthodontic Mini-Screws
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this randomized clinical study is to assess the factors associated with the failure rate of infra-zygomatic crest orthodontic mini-screws used for anchorage reinforcement during orthodontic treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 8, 2027
June 22, 2026
June 1, 2026
1.3 years
June 11, 2026
June 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess the failure rate of infra-zygomatic orthodontic mini-screws over a three-month follow-up period. Failure will be defined as any degree of clinical mobility or loss of stability of the mini-screw.
This is a split-mouth randomized clinical study in which each participant will receive infra-zygomatic mini-screws bilaterally. One side will receive a 10 mm × 1.8 mm mini-screw with immediate loading, while the contralateral side will receive a 12 mm × 2.0 mm mini-screw with delayed loading. The failure rate will be assessed clinically over a three-month follow-up period.Mini-screw failure will be assessed clinically by the presence of mobility or loss of stability.
over a three-month follow-up period
Secondary Outcomes (1)
To assess the failure rate of infra-zygomatic orthodontic mini-screws over a three-month follow-up period. Failure will be defined as any degree of clinical mobility or loss of stability of the mini-screw
Over a three-month follow-up period.
Other Outcomes (1)
Factors Associated with the Failure Rate of Infra-Zygomatic Orthodontic Mini-Screws
From October 25 to September 26
Study Arms (2)
Immediate loading mini-screw group
ACTIVE COMPARATORA 10 mm length and 1.8 mm diameter infra-zygomatic mini-screw will be placed on one side of the maxillary arch and loaded immediately with orthodontic force.
Delayed loading mini-screw group
ACTIVE COMPARATORA 12 mm length and 2.0 mm diameter infra-zygomatic mini-screw will be placed on the contralateral side of the maxillary arch and loaded after a delayed period.
Interventions
A 10 mm length and 1.8 mm diameter infra-zygomatic mini-screw will be placed on one side of the maxillary arch and loaded immediately with orthodontic force.
A 12 mm length and 2.0 mm diameter infra-zygomatic mini-screw will be placed on the contralateral side of the maxillary arch and loaded after a delayed period
Eligibility Criteria
You may qualify if:
- Participants aged 19 to 35 years.
- Both male and female participants.
- Patients requiring absolute anchorage for maxillary arch and orthodontic tooth movement.
- Patients undergoing fixed orthodontic treatment.
- Patients in whom infra-zygomatic mini-screws are indicated for anchorage reinforcement.
- Participants whose oral hygiene status can be clinically assessed.
- Participants willing to provide written informed consent.
You may not qualify if:
- Patients with incomplete history or records
- Patients with a history of previous orthodontic treatment.
- Patients with a history of maxillofacial surgery.
- Patients with a history of head or facial trauma.
- Patients with temporomandibular joint disorder.
- Medically compromised patients.
- Patients with diagnosed syndromes, congenital defects, or facial deformities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanzila Rafiquelead
Study Sites (1)
Bangladesh Medical University (BMU), Dhaka,1000
Dhaka, 1000, Bangladesh
Study Officials
- STUDY DIRECTOR
Mahmood Sajedeen, BDS,FCPS
Bangladesh Medical University (BMU)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 11, 2026
First Posted
June 22, 2026
Study Start
September 1, 2025
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
February 8, 2027
Last Updated
June 22, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share